VDR and neoplasm: Increasing evidence suggests that vitamin D or a 1,25(OH)2D3 supplement can inhibit tumor growth and inactivate Wnt/β-catenin signaling by promoting the binding of β-catenin to the VDR, thus blocking the transduction of Wnt/β-catenin signaling [30,31].